Cytotoxicity of Ruthenium(II) Arene Complexes Containing Functionalized Ferrocenyl β-Diketonate Ligands.
Matthew AllisonPablo Caramés-MéndezBenjamin J HofmannChristopher M PaskRoger M PhillipsRianne M LordPatrick C McGowanPublished in: Organometallics (2023)
The synthesis and characterization of 24 ruthenium(II) arene complexes of the type [( p -cym)RuCl(Fc-acac)] (where p -cym = p-cymene and Fc-acac = functionalized ferrocenyl β-diketonate ligands) are reported, including single-crystal X-ray diffraction for 21 new complexes. Chemosensitivity studies have been conducted against human pancreatic carcinoma (MIA PaCa-2), human colorectal adenocarcinoma p53 -wildtype (HCT116 p53 +/+ ) and normal human retinal epithelial cell lines (APRE-19). The most active complex, which contains a 2-furan-substituted ligand ( 4 ), is 5x more cytotoxic than the analogs 3-furan complex ( 5 ) against MIA PaCa-2. Several complexes were screened under hypoxic conditions and at shorter-time incubations, and their ability to damage DNA was determined by the comet assay. Compounds were also screened for their potential to inhibit the growth of both bacterial and fungal strains.
Keyphrases
- endothelial cells
- induced pluripotent stem cells
- pluripotent stem cells
- escherichia coli
- molecular docking
- quantum dots
- computed tomography
- optical coherence tomography
- radiation therapy
- magnetic resonance
- mass spectrometry
- high throughput
- risk assessment
- circulating tumor
- cell death
- molecular dynamics simulations
- cell proliferation
- human health